Trials / Completed
CompletedNCT00803439
Randomized Study to Compare the Bioavailability of Two Clobetasol Propionate 0.05% Topical Foams
Bioequivalence of Two Clobetasol Propionate 0.05% Topical Foams
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 80 (actual)
- Sponsor
- Padagis LLC · Industry
- Sex
- Female
- Age
- 18 Years – 50 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this study was to compare the relative vasoconstrictive effects of test and reference Clobetasol Propionate 0.05% Topical Foam in healthy, female subjects.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Clobetasol Propionate 0.05% Foam-Reference Product | Small amount applied and evaluated over the course of two days |
| DRUG | Clobetasol Propionate 0.05% Foam-Test product | Small amount applied and evaluated over the course of two days |
Timeline
- Start date
- 2005-04-01
- Primary completion
- 2005-04-01
- Completion
- 2005-04-01
- First posted
- 2008-12-05
- Last updated
- 2021-10-15
Source: ClinicalTrials.gov record NCT00803439. Inclusion in this directory is not an endorsement.